Proton magnetic resonance spectroscopy (1H-MRS) in rheumatic autoimmune diseases: A systematic review.

CONCLUSION: The presence of neurometabolite abnormalities in patients without ouvert CNS manifestations, suggests that systemic inflammation, atherosclerosis or abnormal vascular reactivity may be associated with subclinical CNS manifestations. MRS may be a usefull non-invasive method for screening patients with risk for CNS manifestations. PMID: 33019878 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33019878?dopt=Abstract

Source: Lupus - October 6, 2020 Category: Rheumatology Authors: Frittoli RB, Pereira DR, Rittner L, Appenzeller S Tags: Lupus Source Type: research